Broad Upregulation of PD-L1 and the “PD-L1 Paradox”: The MASH microenvironment drives widespread PD-L1 expression on tumor and immune cells through lipotoxicity 79, chronic inflammation 115, and hypoxia 116, creating a formidable immunosuppressive barrier. The gene discussed is CD274; the disease is neoplasm.